International Journal of Clinical Research

Objective To analyze the impact of low-dose contrast agents on the image quality of patients with chest pain triad during one-stop CT scanning. Methods Sixty patients with chest pain triad admitted to our hospital from July 2022 to July 2023 were included as the research subjects. All patients underwent one-stop CT scans and were randomly divided into a control group (conventional dose contrast agent) and an observation group (low-dose contrast agent), with 30 patients in each group. The scanning results of the two groups were compared. Results There was no statistically significant difference in the imaging quality and diagnostic status of coronary and pulmonary arteries between the two groups of patients (P>0.05), but the incidence of contrast agent nephropathy during the scanning process in the observation group was significantly lower than that in the control group, and the difference was statistically significant (P<0.05). Conclusion In clinical practice, the use of low-dose contrast agents during one-stop CT scanning for patients with chest pain triad has a good image quality maintenance effect, improves diagnostic accuracy, provides reference for clinical treatment, and reduces the occurrence of contrast agent nephropathy, with high safety.

Low dose contrast agent; Triple syndrome of chest pain; One stop CT scanning